A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
Clinical trial NCT07459634 · RECRUITING
Trial details
- NCT number
- NCT07459634
- Sponsor
- Jazz Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-30
- Primary completion
- 2028-01-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.